Randomized Phase-III Study of Low-Dose Cytarabine and Etoposide + /− All-Trans Retinoic Acid in Older Unfit Patients with NPM1-Mutated Acute Myeloid Leukemia

Investigators evaluated the impact of all-trans retinoic acid in combination with non-intensive chemotherapy in older unfit patients (> 60 years) with newly diagnosed NPM1-mutated acute myeloid leukemia.